The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Reduced replication fork speed promotes pancreatic endocrine differentiation and controls graft size
Published version of a preprint
Abstract
Limitations in cell proliferation are important for normal function of differentiated tissues and essential for the safety of cell replacement products made from pluripotent stem cells, which have unlimited proliferative potential. To evaluate whether these limitations can be established pharmacologically, we exposed pancreatic progenitors differentiating from human pluripotent stem cells to small molecules that interfere with cell cycle progression either by inducing G 1 arrest or by impairing S phase entry or S phase completion and determined growth potential, differentiation, and function of insulin-producing endocrine cells. We found that the combination of G 1 arrest with a compromised ability to complete DNA replication promoted the differentiation of pancreatic progenitor cells toward insulin-producing cells and could substitute for endocrine differentiation factors. Reduced replication fork speed during differentiation improved the stability of insulin expression, and the resulting cells protected mice from diabetes without the formation of cystic growths. The proliferative potential of grafts was proportional to the reduction of replication fork speed during pancreatic differentiation. Therefore, a compromised ability to enter and complete S phase is a functionally important property of pancreatic endocrine differentiation, can be achieved by reducing replication fork speed, and is an important determinant of cell-intrinsic limitations of growth.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Adapting the protocol from Sui et al.13,39 we applied aphidicolin (APH), a potent cell growth inhibitor to further mitigate risk of off-target cells and cellular heterogeneity.”
From Scale up manufacturing approach for production of human induced pluripotent stem cell-derived islets using Vertical Wheel® bioreactors (2025) · cites this paper as [39]
In the citing paper
“Thus, the utilization of VW® bioreactor technology and modifications based on the work of Sui et al.39 in our optimized full suspension islet generation method presents a scalable tool for reliably producing human SC-islets from stem cells with controlled and minimal heterogeneity.”
From Scale up manufacturing approach for production of human induced pluripotent stem cell-derived islets using Vertical Wheel® bioreactors (2025) · cites this paper as [39]
In the citing paper
“The differentiation was carried out in a six-stage protocol modified differentiation protocol adopted from previously reported publications13,39.”
From Scale up manufacturing approach for production of human induced pluripotent stem cell-derived islets using Vertical Wheel® bioreactors (2025) · cites this paper as [39]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Raudvere, U., Kolberg, L., Kuzmin, I., Arak, T., Adler, P., Peterson, H., & Vilo, J. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz369 · Cited by 5,045
Generation of Functional Human Pancreatic β Cells In Vitro
Pagliuca, F. W., Millman, J. R., Gürtler, M., Segel, M., Van Dervort, A., Ryu, J. H., Peterson, Q. P., Greiner, D., & Melton, D. A. (2014) · Cell · doi:10.1016/j.cell.2014.09.040 · Cited by 2,025
Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells
Rezania, A., Bruin, J. E., Arora, P., Rubin, A., Batushansky, I., Asadi, A., O'Dwyer, S., Quiskamp, N., Mojibian, M., Albrecht, T., et al. (2014) · Nature Biotechnology · doi:10.1038/nbt.3033 · Cited by 1,575
Suppression of induced pluripotent stem cell generation by the p53–p21 pathway
Hong, H., Takahashi, K., Ichisaka, T., Aoi, T., Kanagawa, O., Nakagawa, M., Okita, K., & Yamanaka, S. (2009) · Nature · doi:10.1038/nature08235 · Cited by 1,301
Linking the p53 tumour suppressor pathway to somatic cell reprogramming
Kawamura, T., Suzuki, J., Wang, Y. V., Menendez, S., Morera, L. B., Raya, A., Wahl, G. M., & Belmonte, J. C. I. (2009) · Nature · doi:10.1038/nature08311 · Cited by 1,115
Self-citationA p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity
Marión, R. M., Strati, K., Li, H., Murga, M., Blanco, R., Ortega, S., Fernandez-Capetillo, O., Serrano, M., & Blasco, M. A. (2009) · Nature · doi:10.1038/nature08287 · Cited by 1,028 · cited 2×
“In KI67-positive cells, single-cell RNA sequencing showed upregulation of genes involved in the P53 signaling pathway (CDKN1A, GADD45A, BAX, MDM2, RPS27L, RRM2) in APH-treated cells.”
BackgroundSenescence impairs successful reprogramming to pluripotent stem cells
Banito, A., Rashid, S. T., Acosta, J. C., Li, S., Pereira, C. F., Geti, I., Pinho, S., Silva, J. C., Azuara, V., Walsh, M., et al. (2009) · Genes & Development · doi:10.1101/gad.1811609 · Cited by 642
Mosaic Copy Number Variation in Human Neurons
McConnell, M. J., Lindberg, M. R., Brennand, K. J., Piper, J. C., Voet, T., Cowing-Zitron, C., Shumilina, S., Lasken, R. S., Vermeesch, J. R., Hall, I. M., et al. (2013) · Science · doi:10.1126/science.1243472 · Cited by 551
Nair, G. G., Liu, J. S., Russ, H. A., Tran, S., Saxton, M. S., Chen, R., Juang, C., Li, M.-L., Nguyen, V. Q., Giacometti, S., et al. (2019) · Nature Cell Biology · doi:10.1038/s41556-018-0271-4 · Cited by 472
Self-citationBarr, A. R., Cooper, S., Heldt, F. S., Butera, F., Stoy, H., Mansfeld, J., Novák, B., & Bakal, C. (2017) · Nature Communications · doi:10.1038/ncomms14728 · Cited by 403
Research works printed but not linked: 53
- 10.1038/nature05537 · DOI · Paper page
- 10.1242/dev.120063 · DOI · Paper page
- 10.2337/db12-0018 · DOI · Paper page
- 10.1016/j.tig.2014.04.001 · DOI
- 10.1016/S0959-437X(97)80005-6 · DOI · Paper page
- 10.1006/mcne.1995.1014 · DOI
- 10.2337/db08-0759 · DOI
- Cheng, 2012, High passage MIN6 cells have impaired insulin secretion with impaired glucose and lipid oxidation, PLoS One, 7, 10.1371/journal.pone.0040868 · DOI
- 10.3390/ijms17091532 · doi:10.3390/ijms17091532
- 10.1507/endocrj.K08E-172 · DOI
- 10.2337/db08-0393 · DOI
- 10.1038/s41467-018-02939-0 · DOI
- 10.1172/JCI72674 · DOI · Paper page
- Egli, 2008, Mediators of reprogramming: transcription factors and transitions through mitosis, Nat Rev Mol Cell Biol, 9, 505, 10.1038/nrm2439 · DOI · Paper page
- 10.1038/nature05879 · DOI · Paper page
- 10.1016/j.ceb.2015.10.001 · DOI
- 10.1038/nature08290 · DOI · Paper page
- 10.1038/nature08285 · DOI · Paper page
- 10.1016/j.stem.2014.10.019 · DOI · Paper page
- 10.1038/nature05953 · DOI · Paper page
- 10.1038/nature06534 · DOI · Paper page
- 10.1038/275458a0 · DOI · Paper page
- Koundrioukoff, 2013, Stepwise activation of the ATR signaling pathway upon increasing replication stress impacts fragile site integrity, PLoS Genet, 9, 10.1371/journal.pgen.1003643 · DOI
- 10.1007/BF00272988 · DOI · Paper page
- 10.2337/db17-0120 · DOI
- 10.1016/S0014-5793(01)02114-7 · DOI · Paper page
- 10.3892/or.2014.3248 · DOI
- 10.1038/bjc.1994.420 · DOI
- Moruno-Manchon, 2017, The G-quadruplex DNA stabilizing drug pyridostatin promotes DNA damage and downregulates transcription of Brca1 in neurons, Aging (Albany NY), 9, 1957, 10.18632/aging.101282 · DOI
- 10.1038/ncb2201 · DOI · Paper page
- 10.1083/jcb.201011083 · DOI · Paper page
- 10.1016/j.celrep.2017.04.055 · DOI · Paper page
- 10.1038/s41586-019-1168-5 · DOI · Paper page
- Taneera, 2019, GNAS gene is an important regulator of insulin secretory capacity in pancreatic β-cells, Gene, 715, 10.1016/j.gene.2019.144028 · DOI
- 10.1016/j.celrep.2013.08.010 · DOI · Paper page
- 10.1073/pnas.0503219102 · DOI
- 10.2337/db16-1355 · DOI
- 10.2337/db10-1192 · DOI
- 10.1038/s41598-018-24075-x · DOI
- 10.1038/s41467-019-09404-6 · DOI
- 10.1016/j.isci.2019.10.063 · DOI
- 10.1523/JNEUROSCI.3707-05.2006 · DOI · Paper page
- 10.1016/j.devcel.2017.02.006 · DOI
- 10.1016/j.stemcr.2018.11.006 · DOI
- 10.1016/j.stemcr.2019.01.012 · DOI
- 10.1242/dev.086165 · DOI · Paper page
- 10.1002/cphg.68 · DOI · Paper page
- 10.1007/s00125-011-2379-y · DOI
- 10.1038/nature08550 · DOI · Paper page
- 10.1083/jcb.140.6.1285 · DOI · Paper page
- 10.1186/s13059-018-1603-1 · DOI · Paper page
- 10.1039/B809590F · DOI
- 10.1007/s10544-010-9398-1 · DOI
Cited by
Characterization of stem-cell-derived islets during differentiation and after implantation
Cuesta-Gomez, N., Verhoeff, K., Jasra, I. T., Pawlick, R., Dadheech, N., & Shapiro, A. M. J. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111238 · Cited by 41
Dadheech, N., Bermúdez de León, M., Czarnecka, Z., Cuesta-Gomez, N., Jasra, I. T., Pawlick, R., Marfil-Garza, B., Sapkota, S., Verhoeff, K., Razavy, H., et al. (2025) · npj Regenerative Medicine · doi:10.1038/s41536-025-00409-y · Cited by 23
Verhoeff, K., Cuesta-Gomez, N., Maghera, J., Dadheech, N., Pawlick, R., Smith, N., O’Gorman, D., Razavy, H., Marfil-Garza, B., Young, L. G., et al. (2025) · Transplantation · doi:10.1097/tp.0000000000005108 · Cited by 16
Metadata
- Authors
- Sui, L., Xin, Y., Du, Q., Georgieva, D., Diedenhofen, G., Haataja, L., Su, Q., Zuccaro, M. V., Kim, J., Fu, J., Xing, Y., He, Y., Baum, D., Goland, R. S., Wang, Y., Oberholzer, J., Barbetti, F., Arvan, P., Kleiner, S., & Egli, D.
- Venue
- JCI Insight
- Published
- 2021-03-08
- Volume
- 6
- Issue
- 5
- ISSN
- 2379-3708
- Cited by
- 48
- References
- 15
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Reduced replication fork speed promotes pancreatic endocrine differentiation and controls graft size. https://app.cochat.ai/papers/10.1172/jci.insight.141553
- The paper
- Sui, L., Xin, Y., Du, Q., Georgieva, D., Diedenhofen, G., Haataja, L., Su, Q., Zuccaro, M. V., Kim, J., Fu, J., Xing, Y., He, Y., Baum, D., Goland, R. S., Wang, Y., Oberholzer, J., Barbetti, F., Arvan, P., Kleiner, S., & Egli, D. (2021). Reduced replication fork speed promotes pancreatic endocrine differentiation and controls graft size. JCI Insight. https://doi.org/10.1172/jci.insight.141553
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.